Position history for JANUS HENDERSON GROUP PLC's holdings in BRIDGEBIO PHARMA INC
JANUS HENDERSON GROUP PLC holds 13.2M shares of BBIO (BRIDGEBIO PHARMA INC), worth $978.6M as of 2026-Q1. The position was increased (+19.8% shares). BBIO represents 0.5% of JANUS HENDERSON GROUP PLC's portfolio.
Current Value
$978.6M
Current Shares
13.2M
Total Value Change
+$869.3M
Total Shares Change
+8.9M
Other major holders of BBIO: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 13.2M |
+19.8% |
| $978.6M |
| 0.5% |
| $64.53 |
45 |
| 2025-Q4 | Increased | 11M | +25.9% | $841.3M | 0.4% | $75.48 | 47 |
| 2025-Q3 | Decreased | 8.7M | -5.8% | $454M | 0.2% | $51.96 | 0 |
| 2025-Q2 | Increased | 9.3M | +29.4% | $400.5M | 0.2% | $44.86 | 47 |
| 2025-Q1 | Increased | 7.2M | +46.1% | $251.7M | 0.1% | $35.11 | 50 |
| 2024-Q4 | Increased | 4.9M | +1.9% | $134.7M | 0.1% | $27.32 | 31 |
| 2024-Q3 | Increased | 4.8M | +11.7% | $122.7M | 0.1% | $24.94 | 34 |
| 2024-Q2 | Increased | 4.3M | +30.2% | $109.3M | 0.1% | $25.33 | 38 |